When medication is consumed it must reach the intended site of action, but what is the degree and rate at which it is absorbed by the human body?
NNE spotlights a vital concept in pharmacology: bioavailability.
Speaking to Christian Carlsen, Business Director of NNE and Morten Allesoe, Principal Consultant at NNE, Medical Cannabis Network gains an insight into the importance of achieving cannabinoid bioavailability, along with understanding ways new therapeutic medications can be developed and monitored to provide effective medication to the patient.
Click here to read the complete article
Shakera Halim ~ HealthEuropa.eu ~
